Published in J Virol on August 01, 1994
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol (1995) 4.27
Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol (1996) 2.82
Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J Virol (1995) 2.43
Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J (1997) 2.42
Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol (1995) 2.22
Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J Virol (1996) 1.71
Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines. J Virol (2001) 1.63
Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J Biol Chem (2008) 1.61
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol (1997) 1.48
Integration-deficient lentiviral vectors: a slow coming of age. Mol Ther (2009) 1.47
Complementation of integrase function in HIV-1 virions. EMBO J (1997) 1.46
Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. J Virol (1996) 1.44
Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J Virol (1998) 1.42
Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J Virol (1995) 1.38
Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase. J Virol (2005) 1.30
Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase. Proc Natl Acad Sci U S A (1996) 1.28
Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. J Virol (1997) 1.27
Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol (2001) 1.23
Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection. J Virol (2004) 1.18
Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy. J Virol (1996) 1.06
3'-end processing and kinetics of 5'-end joining during retroviral integration in vivo. J Virol (1997) 1.04
Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants. Biophys J (2005) 1.04
Preliminary mapping of a putative inhibitor-binding pocket for human immunodeficiency virus type 1 integrase inhibitors. Antimicrob Agents Chemother (2006) 1.02
A three-dimensional model of the human immunodeficiency virus type 1 integration complex. J Comput Aided Mol Des (2005) 1.02
Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle. J Virol (1999) 1.00
Allosteric inhibitor development targeting HIV-1 integrase. ChemMedChem (2011) 1.00
A truncation mutant of the 95-kilodalton subunit of transcription factor IIIC reveals asymmetry in Ty3 integration. Mol Cell Biol (2001) 0.97
Efficiency and fidelity of full-site integration reactions using recombinant simian immunodeficiency virus integrase. J Virol (1999) 0.97
Ty3 integrase mutants defective in reverse transcription or 3'-end processing of extrachromosomal Ty3 DNA. J Virol (1996) 0.96
Disulfide-linked integrase oligomers involving C280 residues are formed in vitro and in vivo but are not essential for human immunodeficiency virus replication. J Virol (2003) 0.95
Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity. J Virol (1996) 0.92
Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases. J Virol (1996) 0.91
The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase. Retrovirology (2014) 0.90
Uneven genetic robustness of HIV-1 integrase. J Virol (2014) 0.88
Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal region of human immunodeficiency virus type 1 integrase. J Virol (1999) 0.87
Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of human immunodeficiency virus type 1 integrase. J Virol (1998) 0.85
Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate. J Virol (2007) 0.85
A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase. J Biol Chem (2014) 0.83
HIV-1 integrase multimerization as a therapeutic target. Curr Top Microbiol Immunol (2015) 0.81
A chimeric Ty3/Moloney murine leukemia virus integrase protein is active in vivo. J Virol (1998) 0.81
Prospects for antisense peptide nucleic acid (PNA) therapies for HIV. Expert Opin Biol Ther (2009) 0.79
Natural single-nucleotide polymorphisms in the 3' region of the HIV-1 pol gene modulate viral replication ability. J Virol (2014) 0.79
Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication. Retrovirology (2008) 0.79
Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication. J Virol (2015) 0.78
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol (1987) 11.36
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol (1989) 9.37
A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev (1989) 8.80
The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell (1990) 7.99
The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell (1990) 7.19
Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc Natl Acad Sci U S A (1986) 6.94
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A (1992) 6.85
Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol (1992) 6.77
Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci U S A (1991) 6.58
HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell (1991) 6.54
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A (1993) 6.44
Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol (1992) 6.07
Retroviral DNA integration directed by HIV integration protein in vitro. Science (1990) 5.87
Integration of human immunodeficiency virus type 1 DNA in vitro. Proc Natl Acad Sci U S A (1990) 4.75
Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J (1993) 4.39
Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res (1991) 4.39
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A (1993) 3.99
Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J Virol (1991) 3.89
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol (1992) 3.85
Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc Natl Acad Sci U S A (1992) 3.55
Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology (1992) 3.43
Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res (1993) 3.42
Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol (1990) 3.32
Complementation between HIV integrase proteins mutated in different domains. EMBO J (1993) 3.32
Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J Virol (1993) 3.28
Retroviral reverse transcription and integration: progress and problems. Annu Rev Cell Biol (1992) 3.26
Genetics of retroviral integration. Annu Rev Genet (1992) 3.16
Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J Biol Chem (1993) 2.69
Retroviral integrase functions as a multimer and can turn over catalytically. J Biol Chem (1992) 2.48
Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J Virol (1994) 2.26
A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J Virol (1992) 2.18
Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein. AIDS Res Hum Retroviruses (1992) 1.82
Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting. J Virol (1990) 1.75
Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.65
Analysis of mutant Moloney murine leukemia viruses containing linker insertion mutations in the 3' region of pol. J Virol (1988) 1.63
Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J Virol (1993) 1.25
Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J Virol (1991) 1.21
Requirement for a conserved serine in both processing and joining activities of retroviral integrase. Proc Natl Acad Sci U S A (1992) 1.20
Development of techniques to analyse the formation of HIV provirus in primary human macrophages. Res Virol (1991) 1.19
Conserved residues Pro-109 and Asp-116 are required for interaction of the human immunodeficiency virus type 1 integrase protein with its viral DNA substrate. J Virol (1993) 1.01
Retrovirus integrase: identification of a potential leucine zipper motif. Protein Eng (1991) 1.01
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res (1995) 7.08
Conservation of high efficiency promoter sequences in Saccharomyces cerevisiae. Nucleic Acids Res (1982) 5.90
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Expression in Saccharomyces cerevisiae of human interferon-alpha directed by the TRP1 5' region. Nucleic Acids Res (1983) 4.01
HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell (1988) 3.36
Efficient synthesis of enzymatically active calf chymosin in Saccharomyces cerevisiae. Gene (1983) 3.25
Reverse transcriptase activity and Ty RNA are associated with virus-like particles in yeast. Nature (1986) 3.07
Sequence variation in dispersed repetitive sequences in Saccharomyces cerevisiae. J Mol Biol (1981) 2.76
Replication in Saccharomyces cerevisiae of plasmid pBR313 carrying DNA from the yeast trpl region. Gene (1979) 2.73
A retrovirus-like strategy for expression of a fusion protein encoded by yeast transposon Ty1. Nature (1985) 2.68
Efficient expression of the Saccharomyces cerevisiae PGK gene depends on an upstream activation sequence but does not require TATA sequences. Mol Cell Biol (1986) 2.63
Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet (2001) 2.36
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
ARS binding factor 1 binds adjacent to RAP1 at the UASs of the yeast glycolytic genes PGK and PYK1. Nucleic Acids Res (1990) 2.31
Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J Virol (1997) 2.24
Detailed alignment of saccharum and sorghum chromosomes: comparative organization of closely related diploid and polyploid genomes. Genetics (1998) 2.24
The functions and relationships of Ty-VLP proteins in yeast reflect those of mammalian retroviral proteins. Cell (1987) 2.23
Synthesis of a gene for the HIV transactivator protein TAT by a novel single stranded approach involving in vivo gap repair. Nucleic Acids Res (1988) 2.22
Long-term ineffectiveness of suspension material and musculofascial suspensions: a rabbit model. Plast Reconstr Surg (1993) 2.02
A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol (2000) 2.00
Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol (1998) 1.97
On the thermodynamical admissibility of the triphasic theory of charged hydrated tissues. J Biomech Eng (2009) 1.96
Characterization of human chromosomal DNA sequences which replicate autonomously in Saccharomyces cerevisiae. Nucleic Acids Res (1984) 1.93
HIV-1 TAT "activates" presynthesized RNA in the nucleus. Cell (1989) 1.89
Regulated high efficiency expression of human interferon-alpha in Saccharomyces cerevisiae. EMBO J (1982) 1.84
Transcriptional control of the Saccharomyces cerevisiae PGK gene by RAP1. Mol Cell Biol (1989) 1.74
A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction. Cell (1990) 1.73
Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology (1996) 1.62
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res (1999) 1.54
Characterisation of the DNA binding domain of the yeast RAP1 protein. Nucleic Acids Res (1990) 1.53
Correlates of avowed happiness. Psychol Bull (1967) 1.52
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol (1997) 1.48
The UAS of the yeast PGK gene contains functionally distinct domains. Nucleic Acids Res (1987) 1.46
Exopolysaccharide production by viridans streptococci in experimental endocarditis. Infect Immun (1984) 1.45
Factors affecting heterologous gene expression in Saccharomyces cerevisiae. Gene (1985) 1.44
Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. J Virol (1996) 1.44
Mutants of Salmonella typhimurium responding to cysteine or methionine: their nature and possible role in the regulation of cysteine biosynthesis. J Gen Microbiol (1975) 1.43
The UAS of the yeast PGK gene is composed of multiple functional elements. Nucleic Acids Res (1988) 1.38
The expression of hybrid HIV:Ty virus-like particles in yeast. Nature (1987) 1.38
Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob Agents Chemother (1998) 1.37
Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity. Nature (1991) 1.36
Multiple control elements in the TRP1 promoter of Saccharomyces cerevisiae. Mol Cell Biol (1986) 1.34
Expression strategies of the yeast retrotransposon Ty: a short sequence directs ribosomal frameshifting. Nucleic Acids Res (1986) 1.33
Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles. EMBO J (1992) 1.32
The identification and high level expression of a protein encoded by the yeast Ty element. EMBO J (1984) 1.31
Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport. J Virol (1997) 1.28
A computational model for collagen fibre remodelling in the arterial wall. J Theor Biol (2004) 1.28
The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man. Br J Exp Pathol (1976) 1.27
Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. J Cell Sci (1995) 1.27
Multiple cis-active elements in the long control region of bovine papillomavirus type 1 (BPV-1). Nucleic Acids Res (1987) 1.27
The regulation of human immunodeficiency virus type-1 gene expression. Eur J Biochem (1996) 1.25
Intron-less RNA injected into the nucleus of Xenopus oocytes accesses a regulated translation control pathway. Nucleic Acids Res (1994) 1.24
Complete nucleotide sequence of a mouse VL30 retro-element. Mol Cell Biol (1988) 1.23